[1]
A. Junaidi, Sabrina Ermayanti, and Afriani Afriani, “Benefits of Conventional Chemotherapy in Progressive Disease Patients with Tyrosine-Kinase Inhibitors: A Case Report”, Bioscmed, vol. 6, no. 14, pp. 2625-2633, Oct. 2022.